Federal Rules Target Hidden Fees in Prescription Drug Pricing

Trump Requires Drug Companies to Disclose Payment Details

Under President Trump, companies managing hundreds of billions in drug spending must now disclose how they get paid.

Federal rules target hidden fees in prescription drug pricing

The Trump administration is preparing a Labor Department regulation requiring pharmacy benefit managers, or PBMs, to disclose detailed information about drug prices, manufacturer payments and other sources of revenue to employer clients, as part of its effort to reduce health care costs, The Wall Street Journal reports.  Expected to take effect in July, the rule […]

U.S. Labor Department Plans Rule Requiring PBM Payment Disclosures

The planned measure covers both the prices PBMs pay for pharmaceuticals and payments they receive from drugmakers.